The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Gilyarov M.Yu.

Pirogov Russian National Research Medical University;
Pirogov Moscow City Clinical Hospital No. 1

Important information about beta-blockers

Authors:

Gilyarov M.Yu.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2025;(10): 92‑94

Read: 196 times

Contact the author
Table of contents

To cite this article:

Gilyarov MYu. Important information about beta-blockers. Non Nocere. New Therapeutic Journal. 2025;(10):92‑94. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Abstract:

Beta-blockers after myocardial infarction: based on materials from the European Congress of Cardiology.

Authors:

Gilyarov M.Yu.

Pirogov Russian National Research Medical University;
Pirogov Moscow City Clinical Hospital No. 1

Close metadata

References:

  1. Ibanez B, Latini R, Rossello X, et al. Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction. N Engl J Med. 2025 Aug 30.  https://doi.org/10.1056/NEJMoa2504735
  2. Munkhaugen J, Kristensen AMD, Halvorsen S, et al. Beta-Blockers after Myocardial Infarction in Patients without Heart Failure. N Engl J Med. 2025 Aug 30.  https://doi.org/10.1056/NEJMoa2505985
  3. Rossello X, Prescott EIB, Kristensen AMD, et al. β-blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trials. Lancet. 2025 Sep 13;406(10508):1128-1137. https://doi.org/10.1016/S0140-6736(25)01592-2
  4. Yndigegn T, Lindahl B, Mars K, et al. Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. N Engl J Med. 2024 Apr 18;390(15):1372-1381. https://doi.org/10.1056/NEJMoa2401479
  5. Watanabe H, Ozasa N, Morimoto T, et al. Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. PLoS One. 2018 Aug 28;13(8):e0199347. https://doi.org/10.1371/journal.pone.0199347
  6. Rossello X, Dominguez-Rodriguez A, Latini R, et al. Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial. Eur Heart J. 2025 Aug 30:ehaf673. https://doi.org/10.1093/eurheartj/ehaf673
  7. Ministry of Health of the Russian Federation. Clinical guidelines. Acute myocardial infarction with ST-segment elevation of the electrocardiogram [Electronic resource]. ID: 157_5. Date accessed: September 2, 2025. https://cr.minzdrav.gov.ru/view-cr/157_5
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.